Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05406414
Other study ID # ADA_1
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 23, 2022
Est. completion date December 31, 2023

Study information

Verified date May 2022
Source University of Aarhus
Contact Mette Kragh, PhD
Phone 9117 1262
Email mekrag@rm.dk
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to examine the effect of a non-pharmacological transdiagnostic sleep intervention as add on to standard treatment for bipolar disorder, depression and attention deficit disorder. Our hypothesis is that the intervention will reduce the severity of the sleep problem and increase sleep quality compared to a control group receiving sleep hygiene education.


Description:

Sleep problems include insomnia, circadian rhythm disorders, hypersomnia, and inadequate sleep hygiene. Patients suffering from mental illness are more likely to suffer from sleep problems than the general population. Sleep problems can aggravate the underlying disorder, cause relapse and suicidal ideation. Sleep problems often persist after the mental disorder is successfully treated. Sleep medication is often used but not recommended for long term use. Non-pharmacological treatment of sleep problems is in demand by patients, but treatment options are few. The present intervention is based on a transdiagnostic manual combining Cognitive Behavioral Therapy for Insomnia with chronotherapy, but more research on the efficacy is warranted. The aim of this study is to investigate whether the intervention reduces the severity of the sleep problem, increases sleep quality, leads to increased sleep efficiency, reduces sleep latency and awakenings, provides better quality of life, increases personal recovery, provides greater readiness to take on a job or reduces consumption of sleep medication.


Recruitment information / eligibility

Status Recruiting
Enrollment 88
Est. completion date December 31, 2023
Est. primary completion date November 30, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age =18 years - F31 Bipolar disorder, F32 unipolar depression or F90 attention deficit disorder - Insomnia Severity Index (ISI) = 14 (exceeding the threshold for a sleep problem) - Sleep problems for 3 months: 3 times a week at least one of the following: - Sleep onset latency = 30 minutes - Wake after sleep onset = 30 minutes - Total sleep time = 11 hours per day - Displaced circadian rhythm; sleeps earlier than 8 P.M. or later than 02 A.M. - Irregular circadian rhythm; bedtime varies = 3 hours throughout the week Exclusion Criteria: - Acutely increased suicide risk (Central Regions guideline for assessment of suicide risk) - Active substance abuse (F10-19) - The sleep problem can be significantly explained by insufficient treatment of physical - disease affecting sleep (documented in patients electronic journal) - Unstable social situation (does not have a permanent residence) - Shift work (= 2 times a week for the last 2 months) - Pregnancy and breast-feeding

Study Design


Intervention

Behavioral:
Transdiagnostic sleep and circadian treatment
The intervention group receives sleep treatment consisting of 6 sessions of 60 minutes each over 6 weeks. The sessions are delivered individually and have the following content: Assessment and introduction to the sleep diary Review of sleep diary - agreements on behavior changes and goals. Information on normal sleep, sleep problems and circadian rhythm Cognitive techniques Introduction to relaxation training Follow-up on goals and plan for prevention relapse of sleep problems
Active waitlist control group
The control group receives sleep hygiene education consisting of a single session in which 10 points of sleep advice are presented. They receive a booklet on how to promote good sleep practice and must work on their own for the next 6 weeks to implement this while waiting for the intervention.

Locations

Country Name City State
Denmark Mette Kragh Aarhus C

Sponsors (1)

Lead Sponsor Collaborator
University of Aarhus

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in the severity of the sleep problem Is measured by Insomnia Severity Index. A self-report instrument measuring the patient's perception of insomnia. The scale ranges from 0 to 28. The higher the score the more severe the insomnia. Is measured at inclusion (baseline/ week 0), at week 2 and at week 6 (endpoint)
Primary Change in sleep quality. Measured by Pittsburgh Sleeping Quality Index (PSQI). The score is between 0 and 21, "0" indicating no difficulty and "21" indicating severe difficulties. Is measured at inclusion (baseline/ week 0) and at week 6 (endpoint).
Secondary Change in well-being Measured on The WHO-5 Well-Being Index (WHO-5). A questionnaire which measures well-being on a scale ranging from 0 to 100, the higher the score the more well-being. Is measured at inclusion (baseline/ week 0), at week 2 and at week 6 (endpoint
Secondary Level of personal recovery Measured by the questionnaire INSPIRE-O. A questionnaire which measures personal recovery on a scale ranging from 5 to 25, the higher the score the more recovery. Is measured at inclusion (baseline/ week 0), at week 2 and at week 6 (endpoint).
Secondary Change in readiness to take on a job Measured by the questionnaire, The Work Ability Index. A score of 0 shows the lowest possibility that the person would take on a job, the score 10 is the highest possibility Is measured at inclusion (baseline/ week 0), at week 2 and at week 6 (endpoint)
Secondary Changes in health-related items. The International EQ-5D-5L questionnaire is applied to estimate quality-adjusted years of life. Is measured at inclusion (baseline/ week 0), at week 2 and at week 6 (endpoint)
Secondary Change in consumption of sleep medications Daily use of sedatives and hypnotics will be measured by medication registration use in sleep diaries during the study period. Is registered daily during the 6 week study period
Secondary Changes in sleep efficiency Is calculated based on the participant's registrations in sleep diaries and by measurements from actigraphs. Is measured daily during the 6 week study period.
Secondary Changes in sleep latency Is calculated based on the participant's registrations in sleep diaries and by measurements from actigraphs. Is measured daily during the 6 week study period
Secondary Changes in sleep nocturnal awakenings Is calculated based on the participant's registrations in sleep diaries and by measurements from actigraphs. Is measured daily during the 6 week study period.
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05777044 - The Effect of Hatha Yoga on Mental Health N/A
Recruiting NCT04977232 - Adjunctive Game Intervention for Anhedonia in MDD Patients N/A
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT03207828 - Testing Interventions for Patients With Fibromyalgia and Depression N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Completed NCT04476446 - An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives Phase 3
Recruiting NCT02783430 - Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease Phase 2/Phase 3
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT04598165 - Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support N/A
Completed NCT03457714 - Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
Recruiting NCT05956912 - Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Completed NCT05588622 - Meru Health Program for Cancer Patients With Depression and Anxiety N/A
Recruiting NCT05234476 - Behavioral Activation Plus Savoring for University Students N/A
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Enrolling by invitation NCT03276585 - Night in Japan Home Sleep Monitoring Study
Terminated NCT03275571 - HIV, Computerized Depression Therapy & Cognition N/A
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A